Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity

Medical Microbiology and Immunology

Volumn 200, Issue 2, 2011, Pages 77-83

  Alborino, F ^a   Burighel, A ^a   Tiller, F W ^b   Van Helden, J ^b   Gabriel, C ^c   Raineri, A ^d   Catapano, R ^d   Stekel, H ^e  

^a Ospedale di Dolo   (Italy)

^b Medizinisches Versorgungszentrum   (Germany)

^c Blutzentrale des Roten Kreuzes Oberoesterreich   (Austria)

^d S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^e KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

ADVIA Centaur Anti HCV; Anti HCV antibody screening; Architect Anti HCV; Elecsys Anti HCV; Hepatitis C virus; Vitros Eci aHCV

Indexed keywords

HEPATITIS C ANTIBODY;

ANTIBODY SCREENING; ARTICLE; AUTOANALYSIS; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MULTICENTER STUDY; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROCONVERSION;

AUTOMATION; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MASS SCREENING; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 79955681183     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-010-0171-0     Document Type: Article

References (15)

1. Choo Q, Kuo G, Weiner A et al (1989) Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 244:359-362 (Pubitemid 19117877)
2. Choo QL, Richman KH, Han JH (1991) Genetic organisation and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455 (Pubitemid 21916435)
3. Lavanchy D (2009) The global burden of hepatitis C. Liver Int 29(Suppl 1):74-81
4. Hallam NF, Fletcher ML, Read SJ, Majid AM, Kurtz JB, Rizza CR (1993) Low risk of sexual transmission of hepatitis C virus. J Med Virol 40:251-253 (Pubitemid 23204104)
5. The Global Burden of Hepatitis C Working Group (2004) Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 44:20-29
6. Strader DB, Wright T, Thomas DL, Seeff LB, American Association for the Study of Liver Diseases (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology 39:1147-1171 (Pubitemid 38428955)
7. Jonas G, Pelzer C, Beckert C, Hausmann M, Kapprell HP (2005) Performance characteristics of the Architect® Anti-HCV assay. J Clin Virol 34:97-103 (Pubitemid 41282797)
8. Richter SS (2003) Laboratory assays for diagnosis and management of hepatitis C virus infection. J Clin Microbiol 41:530-534
9. Pawlotsky JM (2002) Use and interpretation of virological tests for hepatitis C. Hepatology 36:65-73
10. Pawlotsky JM (1999) Diagnostic tests for hepatitis C. J Hepatol 31:71-79
11. Kim S, Kim JH, Yoon S, Park YH, Kim HS (2008) Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection. J Clin Microbiol 46:3919-3923
12. Tiller F, van Helden J, Alborino F et al (2009) Performance evaluation of Elecsys Anti-HCV on modular analytics E170. Clin Chem Lab Med 47:S248-S256
13. Naczinski A, Rieger T (2009) Comparability between Elecsys Anti-HCV (on MODULAR ANALYTICS E170) and Bio-Rad Access HCV Ab PLUS (on Beckman Coulter DxC 880i) in the field using routine samples. Clin Microbiol Infect 15(Suppl 4):P1925
14. Murk JLAN, Simoons-Smit AM, Savelkoul PHM et al (2009) Evaluation of the Roche Cobas HCV immunoassay. Presented at 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland 16-19 May 2009 (abstract P2018)
15. Nick S, Scheiblauer H (2007) Sensitivities of CE-marked HIV, HCV, and HBsAg assays. J Med Virol 79:S59-S64 (Pubitemid 47479877)